Literature DB >> 30047288

New Insights into the Neurobiology of Restless Legs Syndrome.

Sergi Ferré1, Diego García-Borreguero2, Richard P Allen3, Christopher J Earley3.   

Abstract

Restless legs syndrome (RLS) is a common sensorimotor disorder, whose basic components include a sensory experience, akathisia, and a sleep-related motor sign, periodic leg movements during sleep (PLMS), both associated with an enhancement of the individual's arousal state. The present review attempts to integrate the major clinical and experimental neurobiological findings into a heuristic pathogenetic model. The model also integrates the recent findings on RLS genetics indicating that RLS has aspects of a genetically moderated neurodevelopmental disorder involving mainly the cortico-striatal-thalamic-cortical circuits. Brain iron deficiency (BID) remains the key initial pathobiological factor and relates to alterations of iron acquisition by the brain, also moderated by genetic factors. Experimental evidence indicates that BID leads to a hyperdopaminergic and hyperglutamatergic states that determine the dysfunction of cortico-striatal-thalamic-cortical circuits in genetically vulnerable individuals. However, the enhanced arousal mechanisms critical to RLS are better explained by functional changes of the ascending arousal systems. Recent experimental and clinical studies suggest that a BID-induced hypoadenosinergic state provides the link for a putative unified pathophysiological mechanism for sensorimotor signs of RLS and the enhanced arousal state.

Entities:  

Keywords:  adenosine; arousal; brain iron deficiency; dopamine; glutamate; restless legs syndrome

Mesh:

Substances:

Year:  2018        PMID: 30047288      PMCID: PMC9372713          DOI: 10.1177/1073858418791763

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.235


  84 in total

Review 1.  Protein tyrosine phosphatases PTPδ, PTPσ, and LAR: presynaptic hubs for synapse organization.

Authors:  Hideto Takahashi; Ann Marie Craig
Journal:  Trends Neurosci       Date:  2013-07-05       Impact factor: 13.837

Review 2.  Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia.

Authors:  S Ferré; B B Fredholm; M Morelli; P Popoli; K Fuxe
Journal:  Trends Neurosci       Date:  1997-10       Impact factor: 13.837

Review 3.  Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective.

Authors:  Stefan Clemens; David Rye; Shawn Hochman
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

4.  Oral ketamine: a promising treatment for restless legs syndrome.

Authors:  Neeraj Kapur; Robert Friedman
Journal:  Anesth Analg       Date:  2002-06       Impact factor: 5.108

5.  Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis.

Authors:  Diego Garcia-Borreguero; Xavier Guitart; Celia Garcia Malo; Irene Cano-Pumarega; Juan José Granizo; Sergi Ferré
Journal:  Sleep Med       Date:  2018-02-24       Impact factor: 3.492

6.  The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia.

Authors:  Richard P Allen; Sarah Auerbach; Huzefa Bahrain; Michael Auerbach; Christopher J Earley
Journal:  Am J Hematol       Date:  2013-03-12       Impact factor: 10.047

Review 7.  The role of iron in restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley
Journal:  Mov Disord       Date:  2007       Impact factor: 10.338

8.  MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels.

Authors:  Lan Xiong; Hélène Catoire; Patrick Dion; Claudia Gaspar; Ronald G Lafrenière; Simon L Girard; Anastasia Levchenko; Jean-Baptiste Rivière; Laura Fiori; Judith St-Onge; Isabelle Bachand; Pascale Thibodeau; Richard Allen; Christopher Earley; Gustavo Turecki; Jacques Montplaisir; Guy A Rouleau
Journal:  Hum Mol Genet       Date:  2009-01-06       Impact factor: 6.150

Review 9.  Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine.

Authors:  Sergi Ferré
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.160

10.  Pivotal Role of Adenosine Neurotransmission in Restless Legs Syndrome.

Authors:  Sergi Ferré; César Quiroz; Xavier Guitart; William Rea; Arta Seyedian; Estefanía Moreno; Verònica Casadó-Anguera; Manuel Díaz-Ríos; Vicent Casadó; Stefan Clemens; Richard P Allen; Christopher J Earley; Diego García-Borreguero
Journal:  Front Neurosci       Date:  2018-01-08       Impact factor: 4.677

View more
  25 in total

1.  The Adenosine Hypothesis of Restless Legs Syndrome.

Authors:  Sergi Ferré
Journal:  J Caffeine Adenosine Res       Date:  2019-03-14

Review 2.  Restless Legs Syndrome and Other Movement Disorders of Sleep-Treatment Update.

Authors:  Aaro V Salminen; Juliane Winkelmann
Journal:  Curr Treat Options Neurol       Date:  2018-11-09       Impact factor: 3.598

Review 3.  Update on Restless Legs Syndrome: from Mechanisms to Treatment.

Authors:  Paulina Gonzalez-Latapi; Roneil Malkani
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-27       Impact factor: 5.081

4.  Prospective evaluation of sleep disturbances in chronic pancreatitis and its impact on quality of life: a pilot study.

Authors:  Awais Ahmed; Amit N Anand; Ishani Shah; William Yakah; Steven D Freedman; Robert Thomas; Sunil G Sheth
Journal:  Sleep Breath       Date:  2022-01-04       Impact factor: 2.816

Review 5.  Brain-iron deficiency models of restless legs syndrome.

Authors:  Christopher J Earley; Byron C Jones; Sergi Ferré
Journal:  Exp Neurol       Date:  2022-06-30       Impact factor: 5.620

6.  Hyperactivity, dopaminergic abnormalities, iron deficiency and anemia in an in vivo opioid receptors knockout mouse: Implications for the restless legs syndrome.

Authors:  Shangru Lyu; Mark P DeAndrade; Stefan Mueller; Alexander Oksche; Arthur S Walters; Yuqing Li
Journal:  Behav Brain Res       Date:  2019-07-31       Impact factor: 3.332

7.  Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley; Byron C Jones; Erica L Unger
Journal:  Sleep Med       Date:  2020-02-05       Impact factor: 3.492

8.  The role of BTBD9 in the cerebral cortex and the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Hong Xing; Mark P DeAndrade; Pablo D Perez; Keer Zhang; Yuning Liu; Fumiaki Yokoi; Marcelo Febo; Yuqing Li
Journal:  Exp Neurol       Date:  2019-11-09       Impact factor: 5.330

Review 9.  Restless Legs Syndrome: Contemporary Diagnosis and Treatment.

Authors:  Thomas R Gossard; Lynn Marie Trotti; Aleksandar Videnovic; Erik K St Louis
Journal:  Neurotherapeutics       Date:  2021-04-20       Impact factor: 7.620

10.  The Role of BTBD9 in the Cerebellum, Sleep-like Behaviors and the Restless Legs Syndrome.

Authors:  Shangru Lyu; Hong Xing; Mark P DeAndrade; Pablo D Perez; Fumiaki Yokoi; Marcelo Febo; Arthur S Walters; Yuqing Li
Journal:  Neuroscience       Date:  2020-05-22       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.